Lucy Kornblith
Director of Research, Zuckerberg San Francisco General Hospital · University of California (San Francisco) School of Medicine
Credentials: · · · · ·
History
- Present
Zuckerberg San Francisco General Hospital · University of California (San Francisco) School of Medicine
Research
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 780 citations
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 743 citations
Review · Nature Reviews Disease Primers · 2021 · 627 citations
44 papers
41 papers · 23 as a fellow
25 papers
22 papers
18 papers
16 papers · 14 as a resident
- BH
15 papers · 14 as a resident
14 papers
Grants
- 2023–2028
National Institute of General Medical Sciences · R35
Contact PI · $1.6M · University of California, San Francisco
- 2018–2023
Post-Injury Platelet Biology: Mechanisms and Outcomes
National Institute of General Medical Sciences · K23
Contact PI · $995.5K · University of California, San Francisco
Clinical trials
- 2023–2025
Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure - UCSF
Principal investigator · Terminated · Phase 4
University of California, San Francisco
- 2018–2023
Post-Injury Platelet Biology: Mechanisms and Outcomes
Principal investigator · Completed
University of California, San Francisco
- 2026–2028
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
Sub-investigator · Recruiting · Phase 1, Phase 2
Hope Biosciences LLC